U.S. Federal District Court Dismisses ASD and CDEX Lawsuits with Prejudice
ROCKVILLE, Md., Oct 03, 2006 (BUSINESS WIRE) -- CDEX Inc. (OTCBB: CEXI)
announced today that the U.S. Federal District Court in Denver, Colorado has
reviewed and approved the Stipulation to Dismiss that was filed in the Court on
September 29, 2006 as part of a settlement agreement reached between ASD and
CDEX with regards to Civil Action No. 06-CV-426-RDB-CBS. Today, the Court
entered an Order of Dismissal with Prejudice and vacated all pending actions
before the Court.
This action by the Court brings to a final end the patent infringement lawsuit
that was filed by ASD against CDEX. It also brings to a final close CDEX's
counterclaims of invalidity and unenforceability that the company filed in
response to ASD's lawsuit.
"This case was settled in a manner that was fair and equitable to both parties,
while preserving the company's rights and protecting the interests of our
shareholders," said Jim Griffin, CDEX President and CEO.
About CDEX Inc.
CDEX Inc. is a chemical detection technology development company that uses its
expertise to develop and market life safety/public safety products for the
healthcare, homeland security, and brand protection markets. CDEX's ValiMed
Medication Validation System is used for quality assurance to ensure that
high-risk medications that are compounded in hospital pharmacies are the correct
medication, in the correct concentration, and correct diluent before they are
administered to patients. CDEX technology can be used in homeland security
market applications to identify suspicious substances such as trace amounts of
explosives, in liquid or solid form, and illegal drugs for law enforcement in
the homeland security market. CDEX is headquartered in Rockville, Maryland with
its research and development laboratory, engineering, and manufacturing
operations in Tucson, Arizona. For more information, visit www.cdex-inc.com.
Any statements made in this press release which contain information that is not
historical are essentially forward-looking. Many forward-looking statements can
be identified by the use of words such as "expects," "plans," "may,"
"anticipates," "believes," "should," "intends," "estimates," and other words of
similar meaning. These statements are subject to risks and uncertainties that
cannot be predicted or quantified and, consequently, actual results may differ
materially from those expressed or implied by such forward-looking statements.
Such risks are detailed from time-to-time in filings with the Securities and
Exchange Commission. There is no obligation to publicly update any
forward-looking statements.
SOURCE: CDEX, Inc.
|
